We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Microindentation Technology Could Identify Osteoporosis Early

By HospiMedica International staff writers
Posted on 30 Sep 2013
A handheld device for diagnosing the early signs of osteoporosis could be available for clinical use within five years.

Developed by researchers at the University of Southampton (United Kingdom) the device is designed to measure the ability of bone tissue to prevent small cracks growing into full-blown fractures by pressing a microscopic needle into the top layer of bone. More...
Measured electronically, the amount of penetration indicates how fragile the bone tissue is, and therefore the risk of experiencing an osteoporotic fracture later in life. A normal reading might see the needle sink into the bone by around 20 micrometers (0.02 mm); a reading of 40 micrometers might indicate a significant risk of fracture.

In a recent pilot study of the technique, microindentation of a patient's tibiae could clearly identify patients that had a recent osteoporotic fracture from among a group of controls, but the researchers say that further research is required to understand the correlation between microindentation measurements, bone mass, and conventional assessment of in vitro bone tissue fragility through a bone densitometry scan, which measures calcium content per square centimeter using X-rays.

“As the population ages and life expectancy rises in the decades ahead, the cost of treating osteoporotic fractures will increase. One in three women aged over 50 is forecast to experience an osteoporotic fracture in her lifetime and globally, treatment costs are forecast to reach over USD 130 billion by 2050,” said lead researcher Prof. Philipp Thurner, PhD, of the University of Southampton. “The potential improvement in assessing osteoporosis and future fracture risk offered by this new technology could reduce the burden of broken bones for individuals, healthcare systems, and the economy.”

“Bone density scanning is the 'gold-standard' diagnostic tool. However it is not a perfect measure of bone strength and does not show the quality of bone,” said Claire Bowring, medical policy manager at the UK National Osteoporosis Society (Bath, United Kingdom). “New techniques, which look at further measures of bone fragility, are very important in developing our understanding of osteoporosis and bone health and in helping to reduce the number of fragility fractures.”

Related Links:

University of Southampton
UK National Osteoporosis Society



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ultrasound Needle Guidance System
SonoSite L25
Digital Color Doppler Ultrasound System
MS22Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.